BDH Industries Limited (BOM:524828)
544.90
-0.60 (-0.11%)
At close: Aug 17, 2026
BDH Industries Revenue
BDH Industries had revenue of 228.24M INR in the quarter ending June 30, 2026, with 22.55% growth. This brings the company's revenue in the last twelve months to 996.09M, up 44.62% year-over-year. In the fiscal year ending March 31, 2026, BDH Industries had annual revenue of 959.55M with 44.27% growth.
Revenue (ttm)
996.09M
Revenue Growth
+44.62%
P/S Ratio
3.15
Revenue / Employee
10.49M
Employees
95
Market Cap
3.14B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 959.55M | 294.46M | 44.27% |
| Mar 31, 2025 | 665.08M | -193.23M | -22.51% |
| Mar 31, 2024 | 858.31M | 113.74M | 15.28% |
| Mar 31, 2023 | 744.57M | 50.63M | 7.30% |
| Mar 31, 2022 | 693.94M | 119.42M | 20.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Albert David | 3.64B |
| Medico Remedies | 2.38B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 1.99B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Astonea Labs | 1.48B |
| Trident Lifeline | 1.39B |